PDB39 - EMPAGLIFLOZIN FOR PATIENTS IN THE NETHERLANDS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED CARDIOVASCULAR DISEASE- A BUDGET IMPACT MODEL
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.745
https://www.valueinhealthjournal.com/article/S1098-3015(18)34045-2/fulltext
Title :
PDB39 - EMPAGLIFLOZIN FOR PATIENTS IN THE NETHERLANDS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED CARDIOVASCULAR DISEASE- A BUDGET IMPACT MODEL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34045-2&doi=10.1016/j.jval.2018.09.745
First page :
Section Title :
Open access? :
No
Section Order :
143